TNF and inflammatory bowel disease: Because the IBD patients were under variable therapies, receiving different immunomodulators (azathioprine, mercaptopurine, methotrexate) as well as anti-TNF agents, we did not have sufficient subjects in our study to analyze the impact of the respective therapy on the T cell reactivity to CMV.